Page 116 - วารสารการแพทย์แผนไทย ปีที่ 21 ฉบับที่ 2
P. 116

332 วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก      ปีที่ 21  ฉบับที่ 2  พฤษภาคม-สิงหาคม 2566




           dissolve the purple formazan product.  The      2.4  ACE2 inhibition assay
           absorbance of the formazan product of viable      Angiotensin II converting enzyme (ACE2)

           cells was read using the microplate reader at   activity was determined using the angioten-
           570 nm.  The background absorbance was      sin II converting enzyme (ACE2) activity kit
           reduced by the blank and % viability was    (Abcam, MA, USA) and conducted at the

           calculated compared to the control.         Toxicology Laboratory, Department of Medical
                2.3  Anti‑SARS‑CoV‑2 activity using    Sciences. The enzyme solution and reagents
           plaque reduction assay                      were prepared following the procedure de-

                Vero cells were seeded at 3.5x105 cells   scribed in the manufacturer’s protocol.  The
           in 3 mL medium per well of 6–well plates and   plant extracts were diluted with water at the
           left in the incubator for 24 hours to present in   highest concentration, which was not toxic

           monolayer.  The extracts were pre-incubated   to Calu-3 cells. A total of 48 µL of ACE2 assay
           with SARS-CoV-2 at 37˚C for 1 hour before   buffer was mixed with 2 µL diluted ACE2 en-

           transferring 200 µL of the solution with virus   zyme solution and then the solution was added
           particles onto the monolayer of vero E6 cells.    to the diluted extracts or MLN4760 standard
           Viral adsorption was allowed for 1 hour in the   inhibitor (the background and enzyme controls

           CO 2 incubator.  The cells were then washed   were also tested).  The mixed solutions were
           with fresh medium to remove both the un-    placed at room temperature for 15 min. A To-

           bound viral particles and the extract/com-  tal of 40 µL of ACE2 substrate mix was then
           pound.   Total 3 mL of medium was then added   added to the wells and immediately placed in
           to the wells. The semi-solid medium was al-  spectrofluorometer for measurement (Ex/Em =

           lowed to be set and all plates were placed in   320/420 nm) in kinetic mode for 1 hour.  The
           the incubator for 7 days.  The overlaid medium   relative inhibition activity (%) of the sample
           was discarded and cells were fixed with 5%   was calculated using a relative fluorescence

           formaldehyde and then stained with 0.5% (w/v)   unit (RFU) compared to enzyme control.
           crystal violet.  The excess colour was washed      2.5  TMPRSS2 Fluorogenic inhibition
           with tap water.  The plaques were counted   assay

           and % inhibition was calculated compared to      The activity of the TMPRSS2 enzymes
                                             [19]
           the controls (without the compound).   All   was determine using the TMPRSS2 Fluoro-
           extracts were used at previously determined   genic Assay Kit (BPS Bioscience, CA, USA)
           non-toxic concentrations.                   and conducted at the Toxicology Laboratory,
                                                       Department of Medical Sciences. The enzyme
   111   112   113   114   115   116   117   118   119   120   121